Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01129128 · ClinicalTrials.gov registry record · NA
Three Arm Trial of Immune Effects of Echinacea
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT01129128 is a NA study that has completed, run by University of Washington. The registered enrollment target is 67 participants.
The verdict
NCT01129128, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The goal of this study is to determine if either of two, commercially available, Echinacea purpurea products stimulate the immune system. For the study, 60 healthy adults will be randomized to receive one of the two Echinacea purpurea products or placebo for 10 days. Blood will be drawn to assess immune markers just before beginning the study medication, during the 10 day course of medication and after completing the course of medication. It is postulated that adults receiving either of the Echinacea products will have evidence of immune stimulation and those receiving placebo will not.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Echinacea purpurea product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01129128
The ClinicalTrials.gov registry entry for NCT01129128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01129128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01129128 about?
NCT01129128 is a clinical study titled "Three Arm Trial of Immune Effects of Echinacea". The goal of this study is to determine if either of two, commercially available, Echinacea purpurea products stimulate the immune system. For the study, 60 healthy adults will be randomized to receive one of the two Echinacea purpurea products or placebo for 10 days. Blood will be drawn to assess im...
What is the current status of trial NCT01129128?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2010-05. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01129128?
The interventions under investigation include: Placebo (BIOLOGICAL), Echinacea purpurea product (BIOLOGICAL).
Who is sponsoring clinical trial NCT01129128?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.